Notable Call Options Activity on Savient Pharmaceuticals

Shares of Savient Pharmaceuticals

are higher on the session by 1.31%, trading at $2.32. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average. Options traders are focusing on calls today. The strike seeing the heaviest action is the January 2012 $2.50 call, which has traded 3,000 times on open interest of 3,474 contracts. Call volume is outpacing put volume by 61 to 1. Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company in the United States. It engages in developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients refractory to conventional therapy.